デフォルト表紙
市場調査レポート
商品コード
1377949

止血剤の市場:タイプ、製剤、用途別-2023-2030年の世界予測

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
止血剤の市場:タイプ、製剤、用途別-2023-2030年の世界予測
出版日: 2023年11月03日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

止血剤市場は、2022年の30億5,000万米ドルから2030年には47億5,000万米ドルに達すると予測され、予測期間中のCAGRは5.67%です。

止血剤の世界市場

主な市場の統計
基準年[2022] 30億5,000万米ドル
予測年[2023] 32億3,000万米ドル
予測年【2030年 47億5,000万米ドル
CAGR(%) 5.67%
止血剤 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは止血剤市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度:新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています:

1.止血剤市場の市場規模および予測は?

2.止血剤市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は?

3.止血剤市場における競争戦略の窓とは?

4.止血剤市場の最新技術動向と規制の枠組みは?

5.止血剤市場における主要ベンダーの市場シェアは?

6.止血剤市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の蔓延と外科的介入の必要性の増加
      • 低侵襲手術への関心の高まり
    • 抑制要因
      • 製品リコールの発生率の増加
    • 機会
      • バイオポリマーベースの使い捨て製品の台頭止血剤
      • より効率的で的を絞った止血剤を作成するためのナノテクノロジーの統合
    • 課題
      • 止血剤ツールと試薬の使用に伴う感染と相互汚染のリスク
  • 市場セグメンテーション分析
    • タイプ:出血を最小限に抑える効果が高まるため、止血剤の組み合わせの使用を拡大する
    • 製剤:外科的介入中の出血を制御および予防するための粉末の可能性が高まる止血剤
    • 用途:心臓血管手術における失血を防ぎ、確実な成果を保証するための止血剤の重要な役割
  • 市場動向分析
    • 堅牢かつ改善されたヘルスケアストラクチャと、南北アメリカ地域での改善された止血剤の可用性
    • アジア太平洋における政府の投資拡大による医療ツーリズムの加速とヘルスケアインフラの拡大
    • EMEA地域における大手ヘルスケア企業の強固な足場と相まって医療観光客の増加
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 止血剤の市場:タイプ別

  • コラーゲンベースの止血剤
  • 組み合わせ止血剤
  • ゼラチンベースの止血剤
  • 酸化再生セルロース系止血剤
  • トロンビンベースの止血剤

第7章 止血剤の市場配合別

  • マトリックスとジェル止血剤
  • パウダー止血剤
  • シート&パッド止血剤
  • スポンジ止血剤

第8章 止血剤の市場:用途別

  • 心臓血管外科
  • 一般外科
  • 婦人科外科
  • 神経外科
  • 整形外科
  • 再建手術

第9章 南北アメリカの止血剤の市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の止血剤の市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの止血剤の市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別
    • 合併・買収
    • 新製品発売と機能強化
    • 受賞・表彰・拡大

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • A.R. Medicom, Inc.
    • ACTEON Group
    • Advamedica Inc.
    • Advanced Medical Solutions Group PLC
    • Advin Health Care
    • Aegis Lifesciences Private Limited
    • Argon Medical Devices
    • B. Braun SE
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Betatech Medical
    • Convatec Group PLC
    • Cook Group Incorporated
    • Cortis Medtech Pvt Ltd
    • Cotran Corporation
    • Dolphin Sutures by Futura Surgicare Pvt. Ltd.
    • Dynarex Corporation
    • Gelita AG
    • Hangzhou Singclean Medical Products Co.,Ltd.
    • Healthium Medtech Ltd
    • Hemostasis, LLC
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson Services, Inc.
    • Medcura, Inc.
    • Medline Industries, LP
    • Medprin Biotech GmbH
    • Medtronic PLC
    • Meril Life Sciences Pvt. Ltd.
    • Olympus Corporation
    • Pfizer Inc.
    • Rousselot BV by Darling Ingredients International Holding B.V.
    • Royal DSM
    • Shilpa Medicare Limited
    • Stapleline Medizintechnik GmbH
    • Stryker Corporation
    • SYMATESE
    • Teleflex Incorporated
    • Terumo Corporation
    • Zhejiang Perfectseal New Material Technology Co., Ltd.
    • Zimmer Biomet Holdings, Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOSTATS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HEMOSTATS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. HEMOSTATS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. HEMOSTATS MARKET DYNAMICS
  • FIGURE 7. HEMOSTATS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. HEMOSTATS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. HEMOSTATS MARKET SIZE, BY FORMULATION, 2022 VS 2030 (%)
  • FIGURE 10. HEMOSTATS MARKET SIZE, BY FORMULATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. HEMOSTATS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. HEMOSTATS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 12. HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 151. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 152. HEMOSTATS MARKET LICENSE & PRICING
目次
Product Code: MRR-961BA04A2E37

The Hemostats Market is projected to reach USD 4.75 billion by 2030 from USD 3.05 billion in 2022, at a CAGR of 5.67% during the forecast period.

Global Hemostats Market

KEY MARKET STATISTICS
Base Year [2022] USD 3.05 billion
Estimated Year [2023] USD 3.23 billion
Forecast Year [2030] USD 4.75 billion
CAGR (%) 5.67%
Hemostats Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Hemostats Market.

Based on Type, market is studied across Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, and Thrombin-Based Hemostats. The Collagen-Based Hemostats commanded largest market share of 24.22% in 2022, followed by Gelatin-Based Hemostats.

Based on Formulation, market is studied across Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats, and Sponge Hemostats. The Sponge Hemostats commanded largest market share of 27.43% in 2022, followed by Sheet & Pad Hemostats.

Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurological Surgery, Orthopedic Surgery, and Reconstructive Surgery. The Cardiovascular Surgery commanded largest market share of 23.25% in 2022, followed by Gynecological Surgery.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.52% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Hemostats Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Hemostats Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Hemostats Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Hemostats Market?

3. What is the competitive strategic window for identifying opportunities in the Hemostats Market?

4. What are the latest technology trends and regulatory frameworks in the Hemostats Market?

5. What is the market share of the leading vendors in the Hemostats Market?

6. Which modes and strategic moves are suitable for entering the Hemostats Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Hemostats Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
      • 5.1.1.2. Growing inclination toward minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of biopolymer-based disposable hemostats
      • 5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
    • 5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
    • 5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
  • 5.3. Market Trend Analysis
    • 5.3.1. Robust and improving healthcare infrastructure and availability of improved hemostats in the Americas region
    • 5.3.2. Acceleration of medical tourism and expanding healthcare infrastructure with growing investment by the government in the Asia-Pacific
    • 5.3.3. Increase in number of medical tourists coupled with strong foothold of major healthcare companies in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Hemostats Market, by Type

  • 6.1. Introduction
  • 6.2. Collagen-Based Hemostats
  • 6.3. Combination Hemostats
  • 6.4. Gelatin-Based Hemostats
  • 6.5. Oxidized Regenerated Cellulose-Based Hemostats
  • 6.6. Thrombin-Based Hemostats

7. Hemostats Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Hemostats Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecological Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Reconstructive Surgery

9. Americas Hemostats Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hemostats Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
      • 12.3.1.2. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
    • 12.3.2. New Product Launch & Enhancement
      • 12.3.2.1. Baxter Launches PERCLOT Absorbable Hemostatic Powder
      • 12.3.2.2. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
    • 12.3.3. Award, Recognition, & Expansion
      • 12.3.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
      • 12.3.3.2. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
      • 12.3.3.3. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
      • 12.3.3.4. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
      • 12.3.3.5. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
      • 12.3.3.6. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. A.R. Medicom, Inc.
    • 13.1.2. ACTEON Group
    • 13.1.3. Advamedica Inc.
    • 13.1.4. Advanced Medical Solutions Group PLC
    • 13.1.5. Advin Health Care
    • 13.1.6. Aegis Lifesciences Private Limited
    • 13.1.7. Argon Medical Devices
    • 13.1.8. B. Braun SE
    • 13.1.9. Baxter International Inc.
    • 13.1.10. Becton, Dickinson and Company
    • 13.1.11. Betatech Medical
    • 13.1.12. Convatec Group PLC
    • 13.1.13. Cook Group Incorporated
    • 13.1.14. Cortis Medtech Pvt Ltd
    • 13.1.15. Cotran Corporation
    • 13.1.16. Dolphin Sutures by Futura Surgicare Pvt. Ltd.
    • 13.1.17. Dynarex Corporation
    • 13.1.18. Gelita AG
    • 13.1.19. Hangzhou Singclean Medical Products Co.,Ltd.
    • 13.1.20. Healthium Medtech Ltd
    • 13.1.21. Hemostasis, LLC
    • 13.1.22. Integra LifeSciences Holdings Corporation
    • 13.1.23. Johnson & Johnson Services, Inc.
    • 13.1.24. Medcura, Inc.
    • 13.1.25. Medline Industries, LP
    • 13.1.26. Medprin Biotech GmbH
    • 13.1.27. Medtronic PLC
    • 13.1.28. Meril Life Sciences Pvt. Ltd.
    • 13.1.29. Olympus Corporation
    • 13.1.30. Pfizer Inc.
    • 13.1.31. Rousselot BV by Darling Ingredients International Holding B.V.
    • 13.1.32. Royal DSM
    • 13.1.33. Shilpa Medicare Limited
    • 13.1.34. Stapleline Medizintechnik GmbH
    • 13.1.35. Stryker Corporation
    • 13.1.36. SYMATESE
    • 13.1.37. Teleflex Incorporated
    • 13.1.38. Terumo Corporation
    • 13.1.39. Zhejiang Perfectseal New Material Technology Co., Ltd.
    • 13.1.40. Zimmer Biomet Holdings, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing